Skip to content
★ Sign in to follow
YI

YSB Inc. Stock: price and insider trades · Hong Kong

HK·Mcap HK$2.3BHealth Care

No insider purchase over the last 90 days. The latest, by Zhang Buzhen, was filed 01 Jun 2026.

YSB Inc.: what insiders have been doing

Every trade that managers of YSB Inc. disclose to HKEX is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 22 October 2026, 12 filings were filed, from 2 insiders.

The flow runs one way only: 2 insiders bought (12 purchases totalling €1.2M) and nobody sold on the market. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €191k, bought by Zhang Buzhen and made public on 1 June 2026 (0.064% of market cap). Those buying include 2 senior executives.

The clock since the last published purchase (1 June 2026) now reads 160 days. The median gap between a trade and its publication by HKEX is 1 day. This delay matters because a trade only becomes useful information once it is public.

Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 12 filings, this issuer sits above that mark. Our records for YSB Inc. go back to 2023, with 22 purchases and 2 sales on the open market in total.

For comparison within the same sector, see the insider buying recorded at UCB. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
28
Thresholds
n/a
Buy Volume
€2M
22 ops. · all time
Sell Volume
€2M
2 ops. · all time

Who traded when

BuySale
Chen Fei15 buys
Zhang Buzhen6 buys

Since the insiders bought

  • Filed 01 Jun 2026 · 160 days ago · €191k
    +0.7%
    Entry HK$3.53 · Close at T+90 HK$3.56
  • Filed 25 Mar 2026 · 228 days ago
    -31.3%
    Entry HK$5.30 · Close 22 Oct 2026 HK$3.64

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 9,756 of 26,897 companies
58.3
score / 100
Value
76
Quality
40
FCF yld27%
Earn yld6.6%
EV/EBITDA8.8x
ROE7.9%
Gross mgn11%
Net mgn0.7%
Debt/EBITDA1.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$3.40
Analyst consensus
·
Income statement
RevenueHK$21B
Gross profitHK$2.3B11% margin
EBITDAHK$301.7M1% margin
Net incomeHK$153M0.9% margin
Valuation
PER (trailing)11.3x
P/Book0.8x
Beta0.44
Balance sheet & cash
Market capHK$2.3B
Total debtHK$327.5M
Free Cash FlowHK$619.5M
Debt / Equity13%
Profitability & ownership
ROE7.9%
ROA0.9%
% insiders39.2%
% institutions7.8%
Last declaration on 1 June 2026
Declarations28 total
  • ▲
    DirectorExecutives
    2M HKD15HKEX
    500,000 shares@ HK$3.48820.064% mcap41.0% of flowShareXHKGHKEX:DA20260601E00189
    Canonical exit: 27 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    565,200 HKD3HKEX
    100,000 shares@ HK$5.6520.023% mcap13.2% of flowShareXHKGHKEX:DA20260422E00524
    Canonical exit: 21 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    818,777 HKD4HKEX
    153,200 shares@ HK$5.34450.034% mcap19.4% of flowShareXHKGHKEX:DA20260409E00042
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    47,000 HKD2HKEX
    9,400 shares@ HK$5.000.0020% mcap1.1% of flowShareXHKGHKEX:DA20260330E00020
    Canonical exit: 23 Jun 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD5HKEX
    200,000 shares@ HK$5.31140.044% mcap25.2% of flowShareXHKGHKEX:DA20260330E00021
    Canonical exit: 24 Jun 2026 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    6,510,305 sharesShareXHKGHKEX:DA20260325E00186
    Canonical exit: 22 Jun 2026 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    26,041,213 sharesShareXHKGHKEX:DA20260325E00201
    Canonical exit: 22 Jun 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD11HKEX
    150,000 shares@ HK$6.752.4% of flowShareXHKGHKEX:DA20251124E00300
    Canonical exit: 22 Feb 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD11HKEX
    200,000 shares@ HK$6.9643.3% of flowShareXHKGHKEX:DA20251120E00321
    Canonical exit: 18 Feb 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD11HKEX
    200,000 shares@ HK$7.2133.4% of flowShareXHKGHKEX:DA20251119E00265
    Canonical exit: 17 Feb 2026 (T+90)
  • ▲
    DirectorExecutives
    819,700 HKD11HKEX
    100,000 shares@ HK$8.1971.9% of flowShareXHKGHKEX:DA20251112E00303
    Canonical exit: 10 Feb 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD11HKEX
    200,000 shares@ HK$7.693.7% of flowShareXHKGHKEX:DA20251106E00307
    Canonical exit: 4 Feb 2026 (T+90)
  • ▲
    DirectorExecutives
    514,910 HKD11HKEX
    50,000 shares@ HK$10.29821.2% of flowShareXHKGHKEX:DA20250821E00391
    Canonical exit: 19 Nov 2025 (T+90)
  • ▲
    DirectorExecutives
    477,450 HKD11HKEX
    50,000 shares@ HK$9.5491.1% of flowShareXHKGHKEX:DA20250625E00273
    Canonical exit: 23 Sept 2025 (T+90)
  • ▲
    DirectorExecutives
    1M HKD11HKEX
    100,000 shares@ HK$10.3422.5% of flowShareXHKGHKEX:DA20250617E00200
    Canonical exit: 15 Sept 2025 (T+90)
  • ▲
    DirectorExecutives
    501,000 HKD11HKEX
    50,000 shares@ HK$10.021.2% of flowShareXHKGHKEX:DA20250611E00296
    Canonical exit: 9 Sept 2025 (T+90)
  • ▲
    DirectorExecutives
    500,000 HKD11HKEX
    50,000 shares@ HK$10.001.2% of flowShareXHKGHKEX:DA20250604E00394
    Canonical exit: 2 Sept 2025 (T+90)
  • ▲
    DirectorExecutives
    832,000 HKD11HKEX
    100,000 shares@ HK$8.322.0% of flowShareXHKGHKEX:DA20250521E00210
    Canonical exit: 19 Aug 2025 (T+90)
  • ▲
    DirectorExecutives
    761,000 HKD11HKEX
    100,000 shares@ HK$7.611.9% of flowShareXHKGHKEX:DA20250515E00374
    Canonical exit: 13 Aug 2025 (T+90)
  • ▲
    DirectorExecutives
    2M HKD11HKEX
    300,000 shares@ HK$6.354.6% of flowShareXHKGHKEX:DA20250423E00405
    Canonical exit: 22 Jul 2025 (T+90)
  • ▲
    DirectorExecutives
    1M HKD11HKEX
    200,000 shares@ HK$6.313.1% of flowShareXHKGHKEX:DA20250422E00485
    Canonical exit: 21 Jul 2025 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    600,000 sharesShareXHKGHKEX:DA20241111E00108
    Canonical exit: 4 Feb 2025 (T+90)
  • ●
    DirectorExecutives
    3M HKD12HKEX
    1,000,000 shares@ HK$3.11477.7% of flowShareXHKGHKEX:DA20240930E00544
  • ●
    DirectorExecutives
    3M HKD12HKEX
    1,000,000 shares@ HK$3.11477.7% of flowShareXHKGHKEX:DA20240910E00214
  • ▼
    DirectorExecutives
    4M HKD12HKEX
    180,000 shares@ HK$20.47969.3% of flowShareXHKGHKEX:DA20231214E00434

25 of 28 declarations

About YSB Inc.

YSB Inc. is a company operating in the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange, XHKG.